Candriam Equities L Oncology Impact R/ LU1864482945 /
| NAV5/26/2023 | Chg.+0.2200 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 149.9200GBP | +0.15% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | - | -5.91 | 1.22 | 1.97 | -2.19 | 6.24 | -1.60 | 6.65 | -1.78 | 1.67 | -3.00 | 1.57 | +0.35% |
| 2022 | -9.65 | -1.77 | 6.64 | -1.28 | -1.72 | 3.81 | 4.15 | 1.29 | -0.68 | 3.77 | 2.54 | -4.41 | +1.60% |
| 2023 | -0.20 | -2.27 | -0.74 | 1.14 | 0.10 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 13.52% | 14.01% | 16.76% | -% | -% |
| Sharpe ratio | -0.62 | -0.82 | 0.21 | - | - |
| Best month | +1.14% | +2.54% | +4.15% | +6.65% | - |
| Worst month | -4.41% | -4.41% | -4.41% | -9.65% | - |
| Maximum loss | -7.51% | -9.43% | -10.14% | - | - |
| Outperformance | - | - | - | - | - |
All quotes in GBP
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,189.5400 | +5.02% | +15.62% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,336.7200 | +5.15% | +16.06% | |
| Candriam Equities L Oncology Imp... | reinvestment | 195.9800 | +0.19% | +4.67% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,116.8000 | +7.08% | +14.78% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,481.8800 | +4.69% | +14.51% | |
| Candriam Equities L Oncology Imp... | reinvestment | 230.1000 | +3.76% | +14.32% | |
| Candriam Equities L Oncology Imp... | paying dividend | 222.5400 | +3.71% | +11.44% | |
| Candriam Equities L Oncology Imp... | paying dividend | 178.6700 | +4.58% | +14.16% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,297.0000 | +2.20% | +13.61% | |
| Candriam Equities L Oncology Imp... | reinvestment | 149.9200 | +6.97% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,974.2000 | +1.14% | +7.57% | |
| Candriam Equities L Oncology Imp... | reinvestment | 241.7900 | +4.63% | +17.14% | |
| Candriam Equities L Oncology Imp... | reinvestment | 196.2600 | -0.20% | +3.33% | |
| Candriam Equities L Oncology Imp... | reinvestment | 262.7100 | +4.58% | +14.17% | |
| Candriam Equities L Oncology Imp... | reinvestment | 181.5200 | +1.07% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,634.9099 | +6.41% | +14.36% | |
| Candriam Equities L Oncology Imp... | reinvestment | 253.1300 | +5.42% | +11.28% |
Performance
| YTD | -1.97% | ||
|---|---|---|---|
| 6 Months | -4.01% | ||
| 1 Year | +6.97% | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | -0.05% | ||
| Year | |||
| 2022 | +1.60% | ||
| 2021 | +0.35% | ||